In virtually every country in the world, governments, social security fund managers and health insurers are struggling with ever increasing drug bills. This note explains cost drivers, provides insights...
Counterfeit and substandard drugs jeopardize health and waste money. Andreas Seiter reviews dimensions of the problem and contributing factors, and how countries can ensure drug quality. Pharmaceutical...